Showing results (261-270 of 340) with videos related to
Sort By:
Pageof 34
Breast Cancer Research : BCR|December 3, 2011
Phosphatidylinositol 3-kinase pathway activation in breast cancer brain metastasesBarbara Adamo, Allison M Deal, Emily Burrows, et al.The Oncologist|December 15, 2015
A Multidisciplinary Breast Cancer Brain Metastases Clinic: The University of North Carolina ExperienceMegan J McKee, Kevin Keith, Allison M Deal, et al.Journal for Immunotherapy of Cancer|August 1, 2023
Patient-reported outcomes in CD30-directed CAR-T cells against relapsed/refractory CD30+ lymphomasNicholas P Tschernia, Hillary Heiling, Allison M Deal, et al.Journal of Geriatric Oncology|August 14, 2021
Geriatric-assessment-identified functional deficits among adults with multiple myeloma with normal performance statusChristopher E Jensen, Sanah N Vohra, Kirsten A Nyrop, et al.Plos One|May 8, 2013
Pharmacokinetics and efficacy of PEGylated liposomal doxorubicin in an intracranial model of breast cancerCarey K Anders, Barbara Adamo, Olga Karginova, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 13, 2022
Families Addressing Cancer Together (FACT): feasibility and acceptability of a web-based psychosocial intervention for parents with cancerEliza M Park, Allison M Deal, Hillary M Heiling, et al.British Journal of Cancer|October 9, 2018
Phase II trial of palbociclib in patients with metastatic urothelial cancer after failure of first-line chemotherapyTracy L Rose, David D Chism, Ajjai S Alva, et al.Journal of Geriatric Oncology|December 27, 2021
Phase Ib trial of lenalidomide as post-remission therapy for older adults with acute myeloid leukemia: Safety and longitudinal assessment of geriatric functional domainsJustin D Woods, Joshua F Zeidner, Hendrik W Van Deventer, et al.Breast Cancer Research and Treatment|October 12, 2018
Correction to: Measuring and understanding adherence in a home-based exercise intervention during chemotherapy for early breast cancerK A Nyrop, A M Deal, S K Choi, et al.Cancers|November 13, 2025
Psychometric Properties and Interpretability of PRO-CTCAE® Average Composite Scores as a Summary Metric of Symptomatic Adverse Event BurdenMinji K Lee, Sandra A Mitchell, Ethan Basch, et al.Pageof 34